HCV-IN-39 (Compound 18a) is a potent, orally active nucleoside inhibitor of hepatitis C virus (HCV), effective against the GT1a replicon (EC50: 0.259 µM), GT1b replicon (EC50: 0.434 µM), and GT1b CES1 replicon (EC50: 0.069 µM).
Molecular Weight:
594.32
CAS Number:
[2087916-66-1]
Formula:
C21H26BrFN3O9P
Target:
Others|||HCV Protease
T64202
* VAT and and shipping costs not included. Errors and price changes excepted
